It binds to heavy metals, environmental pollutants, and other harmful toxins, facilitating their elimination from the body
Ao contrrio, perdas de ambas (carnitina e acilcarnitinas) durante sesses de dilise levam a quedas acentuadas na concentrao plasmtica (aproximadamente 80%), sendo compensadas por meio da liberao de carnitina pelos msculos que, com o tempo, tambm se tornam depletados 7,23,24
These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
Further investigation is needed to understand the underlying mechanisms
Animal data is strong